N-[(2S)-1-[[(2S)-1-[4-[(6aS)-3-[3-[[(6aS)-2-methoxy-8-(4-methoxyphenyl)-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]propoxy]-2-methoxy-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-8-yl]anilino]-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]-6-[3-(4-cyanophenoxy)-2,5-dioxopyrrol-1-yl]hexanamide

C67H67N9O13 — CID 138732299

IUPACN-[(2S)-1-[[(2S)-1-[4-[(6aS)-3-[3-[[(6aS)-2-methoxy-8-(4-methoxyphenyl)-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]propoxy]-2-methoxy-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-8-yl]anilino]-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]-6-[3-(4-cyanophenoxy)-2,5-dioxopyrrol-1-yl]hexanamide
SMILESCOc1ccc(C2=CN3C(=O)c4cc(OC)c(OCCCOc5cc6c(cc5OC)C(=O)N5C=C(c7ccc(NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)CCCCCN8C(=O)C=C(Oc9ccc(C#N)cc9)C8=O)C(C)C)cc7)C[C@H]5C=N6)cc4N=C[C@@H]3C2)cc1
InChIInChI=1S/C67H67N9O13/c1-39(2)62(73-60(77)11-8-7-9-24-74-61(78)33-59(67(74)83)89-50-20-12-41(34-68)13-21-50)64(80)71-40(3)63(79)72-46-18-14-42(15-19-46)44-27-47-35-69-53-31-57(55(85-5)29-51(53)65(81)75(47)37-44)87-25-10-26-88-58-32-54-52(30-56(58)86-6)66(82)76-38-45(28-48(76)36-70-54)43-16-22-49(84-4)23-17-43/h12-23,29-33,35-40,47-48,62H,7-11,24-28H2,1-6H3,(H,71,80)(H,72,79)(H,73,77)/t40-,47-,48-,62-/m0/s1
InChIKeyHTQVSXDXXUNUTM-KZJDSHCZSA-N
MW1206.32 g/mol
LogP8.85
Rot. Bonds25

About N-[(2S)-1-[[(2S)-1-[4-[(6aS)-3-[3-[[(6aS)-2-methoxy-8-(4-methoxyphenyl)-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]propoxy]-2-methoxy-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-8-yl]anilino]-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]-6-[3-(4-cyanophenoxy)-2,5-dioxopyrrol-1-yl]hexanamide

N-[(2S)-1-[[(2S)-1-[4-[(6aS)-3-[3-[[(6aS)-2-methoxy-8-(4-methoxyphenyl)-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]propoxy]-2-methoxy-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-8-yl]anilino]-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]-6-[3-(4-cyanophenoxy)-2,5-dioxopyrrol-1-yl]hexanamide (PubChem CID 138732299) has the molecular formula C67H67N9O13 and a molecular weight of 1206.32 g/mol. Its IUPAC name is N-[(2S)-1-[[(2S)-1-[4-[(6aS)-3-[3-[[(6aS)-2-methoxy-8-(4-methoxyphenyl)-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]propoxy]-2-methoxy-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-8-yl]anilino]-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]-6-[3-(4-cyanophenoxy)-2,5-dioxopyrrol-1-yl]hexanamide.

Molecular Properties

Compound NameN-[(2S)-1-[[(2S)-1-[4-[(6aS)-3-[3-[[(6aS)-2-methoxy-8-(4-methoxyphenyl)-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]propoxy]-2-methoxy-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-8-yl]anilino]-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]-6-[3-(4-cyanophenoxy)-2,5-dioxopyrrol-1-yl]hexanamide
PubChem CID138732299
Molecular FormulaC67H67N9O13
Molecular Weight1206.32 g/mol
Exact Mass1205.49
IUPAC NameN-[(2S)-1-[[(2S)-1-[4-[(6aS)-3-[3-[[(6aS)-2-methoxy-8-(4-methoxyphenyl)-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]propoxy]-2-methoxy-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-8-yl]anilino]-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]-6-[3-(4-cyanophenoxy)-2,5-dioxopyrrol-1-yl]hexanamide
SMILESCOc1ccc(C2=CN3C(=O)c4cc(OC)c(OCCCOc5cc6c(cc5OC)C(=O)N5C=C(c7ccc(NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)CCCCCN8C(=O)C=C(Oc9ccc(C#N)cc9)C8=O)C(C)C)cc7)C[C@H]5C=N6)cc4N=C[C@@H]3C2)cc1
InChIInChI=1S/C67H67N9O13/c1-39(2)62(73-60(77)11-8-7-9-24-74-61(78)33-59(67(74)83)89-50-20-12-41(34-68)13-21-50)64(80)71-40(3)63(79)72-46-18-14-42(15-19-46)44-27-47-35-69-53-31-57(55(85-5)29-51(53)65(81)75(47)37-44)87-25-10-26-88-58-32-54-52(30-56(58)86-6)66(82)76-38-45(28-48(76)36-70-54)43-16-22-49(84-4)23-17-43/h12-23,29-33,35-40,47-48,62H,7-11,24-28H2,1-6H3,(H,71,80)(H,72,79)(H,73,77)/t40-,47-,48-,62-/m0/s1
InChIKeyHTQVSXDXXUNUTM-KZJDSHCZSA-N
XLogP8.85
TPSA269.19 Ų
H-Bond Donors3
H-Bond Acceptors16
Rotatable Bonds25
Heavy Atoms89
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001206.32
LogP ≤ 58.85
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1016

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'phthalimide', 'substructure': 'N/A'}

Analyze N-[(2S)-1-[[(2S)-1-[4-[(6aS)-3-[3-[[(6aS)-2-methoxy-8-(4-methoxyphenyl)-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]propoxy]-2-methoxy-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-8-yl]anilino]-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]-6-[3-(4-cyanophenoxy)-2,5-dioxopyrrol-1-yl]hexanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[(2S)-1-[[(2S)-1-[4-[(6aS)-3-[3-[[(6aS)-2-methoxy-8-(4-methoxyphenyl)-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]propoxy]-2-methoxy-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-8-yl]anilino]-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]-6-[3-(4-cyanophenoxy)-2,5-dioxopyrrol-1-yl]hexanamide?
The IUPAC name of N-[(2S)-1-[[(2S)-1-[4-[(6aS)-3-[3-[[(6aS)-2-methoxy-8-(4-methoxyphenyl)-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]propoxy]-2-methoxy-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-8-yl]anilino]-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]-6-[3-(4-cyanophenoxy)-2,5-dioxopyrrol-1-yl]hexanamide (CID 138732299) is N-[(2S)-1-[[(2S)-1-[4-[(6aS)-3-[3-[[(6aS)-2-methoxy-8-(4-methoxyphenyl)-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]propoxy]-2-methoxy-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-8-yl]anilino]-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]-6-[3-(4-cyanophenoxy)-2,5-dioxopyrrol-1-yl]hexanamide.
What is the SMILES notation for N-[(2S)-1-[[(2S)-1-[4-[(6aS)-3-[3-[[(6aS)-2-methoxy-8-(4-methoxyphenyl)-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]propoxy]-2-methoxy-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-8-yl]anilino]-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]-6-[3-(4-cyanophenoxy)-2,5-dioxopyrrol-1-yl]hexanamide?
The canonical SMILES for N-[(2S)-1-[[(2S)-1-[4-[(6aS)-3-[3-[[(6aS)-2-methoxy-8-(4-methoxyphenyl)-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]propoxy]-2-methoxy-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-8-yl]anilino]-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]-6-[3-(4-cyanophenoxy)-2,5-dioxopyrrol-1-yl]hexanamide is COc1ccc(C2=CN3C(=O)c4cc(OC)c(OCCCOc5cc6c(cc5OC)C(=O)N5C=C(c7ccc(NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)CCCCCN8C(=O)C=C(Oc9ccc(C#N)cc9)C8=O)C(C)C)cc7)C[C@H]5C=N6)cc4N=C[C@@H]3C2)cc1.
What is the InChIKey of N-[(2S)-1-[[(2S)-1-[4-[(6aS)-3-[3-[[(6aS)-2-methoxy-8-(4-methoxyphenyl)-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]propoxy]-2-methoxy-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-8-yl]anilino]-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]-6-[3-(4-cyanophenoxy)-2,5-dioxopyrrol-1-yl]hexanamide?
The InChIKey is HTQVSXDXXUNUTM-KZJDSHCZSA-N. The full InChI is InChI=1S/C67H67N9O13/c1-39(2)62(73-60(77)11-8-7-9-24-74-61(78)33-59(67(74)83)89-50-20-12-41(34-68)13-21-50)64(80)71-40(3)63(79)72-46-18-14-42(15-19-46)44-27-47-35-69-53-31-57(55(85-5)29-51(53)65(81)75(47)37-44)87-25-10-26-88-58-32-54-52(30-56(58)86-6)66(82)76-38-45(28-48(76)36-70-54)43-16-22-49(84-4)23-17-43/h12-23,29-33,35-40,47-48,62H,7-11,24-28H2,1-6H3,(H,71,80)(H,72,79)(H,73,77)/t40-,47-,48-,62-/m0/s1.
What are the key properties of N-[(2S)-1-[[(2S)-1-[4-[(6aS)-3-[3-[[(6aS)-2-methoxy-8-(4-methoxyphenyl)-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]propoxy]-2-methoxy-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-8-yl]anilino]-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]-6-[3-(4-cyanophenoxy)-2,5-dioxopyrrol-1-yl]hexanamide?
N-[(2S)-1-[[(2S)-1-[4-[(6aS)-3-[3-[[(6aS)-2-methoxy-8-(4-methoxyphenyl)-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]propoxy]-2-methoxy-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-8-yl]anilino]-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]-6-[3-(4-cyanophenoxy)-2,5-dioxopyrrol-1-yl]hexanamide has a molecular weight of 1206.32 g/mol, XLogP of 8.85, 25 rotatable bonds, 3 hydrogen bond donors, and 16 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(2S)-1-[[(2S)-1-[4-[(6aS)-3-[3-[[(6aS)-2-methoxy-8-(4-methoxyphenyl)-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]propoxy]-2-methoxy-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-8-yl]anilino]-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]-6-[3-(4-cyanophenoxy)-2,5-dioxopyrrol-1-yl]hexanamide is sourced from PubChem (CID 138732299), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).